Minimal Clinically Important Difference in Parkinson's Disease as Assessed in Pivotal Trials of Pramipexole Extended Release

Background. The minimal clinically important difference (MCID) is the smallest change in an outcome measure that is meaningful for patients. Objectives. To calculate the MCID for Unified Parkinson's Disease Rating Scale (UPDRS) scores in early Parkinson's disease (EPD) and for UPDRS scores...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Hauser, Robert A., Gordon, Mark Forrest, Mizuno, Yoshikuni, Poewe, Werner, Barone, Paolo, Schapira, Anthony H., Rascol, Olivier, Debieuvre, Catherine, Fräßdorf, Mandy
Formato: Artigo
Idioma:Inglês
Publicado em: Hindawi Publishing Corporation 2014
Assuntos:
Clinical Study
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3995302/
https://ncbi.nlm.nih.gov/pubmed/24800101
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2014/467131
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados